Om

TempraMed Technologies Ltd. is a medical technology company focused on temperature-controlled storage and management solutions for sensitive medications. TempraMed develops patented, FDA-registered thermal insulation devices designed to protect products such as insulin, GLP-1 therapies, biologics, and epinephrine auto-injectors without batteries, refrigeration, or external power. Its commercial portfolio includes VIVI Cap, VIVI Cap Smart, VIVI Epi, and VIVI Med, which support both personal use and connected medication management. The company serves patients, healthcare providers, pharmacies, and health systems that need reliable protection for injectable therapies in daily life and travel. TempraMed Technologies Ltd. plays a specialized role in the healthcare market by helping preserve medication integrity and improve portability for temperature-sensitive treatments.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TEMPRAMED TECHNOLOGIES MED ENDAVU: Køb TempraMed Technologies ($VIVI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i TempraMed Technologies, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.